Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Dachau
Clinical trial register · Germany

Clinical Trials in Dachau, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5062 matching records held by the registry are in this view. Synced 20 Oct 2026, 03:18 UTC
5062
Studies in scope
all four open statuses
2873
Recruiting now
open to new participants
988
Lead sponsors
across recruiting studies
Top sites
Berlin 1586 Hamburg 889 Essen 766 Dresden 716 Heidelberg 627
Narrow the registerReset
Recruitment status
Phase
Site location
Berlin1586 Hamburg889 Essen766 Dresden716 Heidelberg627
All 639 locations
Target enrolment
to

Trials with a site in Dachau

35 of 5062 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Recruiting
Janssen Research & Development, LLC
Phase 3
644
Berlin, Dachau, Dresden, Erlangen, Halle, Hanover, Jena, Karlshorst
2026-05-23
Recruiting
Janssen Research & Development, LLC
Phase 3
460
Berlin, Dachau, Dresden, Erlangen, Halle, Hanover, Karlshorst, Kiel
2026-05-22
Recruiting
Eli Lilly and Company
Phase 2
531
Berlin, Dachau, Hamburg, Karlsruhe, Leipzig, Offenbach
2026-05-06
Recruiting
Eli Lilly and Company
Phase 2
60
Berlin, Dachau, Halle, Ludwigshafen, Ulm
2026-05-04
Recruiting
Eli Lilly and Company
Phase 2
60
Berlin, Dachau, Halle, Ludwigshafen, Ulm
2026-05-04
Recruiting
Eli Lilly and Company
Phase 2
252
Berlin, Dachau, Erlangen, Regensburg, Ulm
2025-11-10
Recruiting
Janssen Research & Development, LLC
Phase 2/3
1,092
Berlin, Dachau, Erlangen, Halle, Hanover, Jerichow, Kiel, Leipzig
2025-10-03
Recruiting
Janssen Research & Development, LLC
Phase 3
882
Aachen, Berlin, Dachau, Erlangen, Halle, Hanover, Jerichow, Kiel
2025-10-01
Active, closed
Cinclus Pharma Holding AB
Phase 3
500
Mannheim, Dachau, Munich, Leipzig
2025-09-11
Active, closed
AbbVie
Phase 3
573
Freiburg im Breisgau, Ulm, Dachau, Erlangen, Regensburg, Frankfurt am Main, Essen, Minden
2025-06-17
Recruiting
Sanofi
Observational
150
Aschaffenburg, Augsburg, Dachau, Erlangen, Giessen, Wetzlar, Osnabrück, Weyhe-Kirchweyhe
2025-05-28
Recruiting
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
NCT07012395Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
Spyre Therapeutics, Inc.
Phase 2
645
Berlin, Brandenburg an der Havel, Dachau, Frankfurt am Main, Kiel, Leipzig, Munich, Ulm
2025-05-27
Recruiting
University Hospital Schleswig-Holstein
Phase 2/3
459
Kiel, Aachen, Augsburg, Bamberg, Berlin, Bremen, Cologne, Dachau
2024-09-12
Active, closed
GlaxoSmithKline
Phase 3
10,212
Weinheim, Dachau, Munich, Hanover, Cologne, Essen, Goch, Freiberg
2024-08-01
Recruiting
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
385
Berlin, Dachau, Duisburg, Frankfurt am Main, Halle, Heidelberg, Kiel, Leipzig
2024-07-18
Recruiting
Deutsches Herzzentrum Muenchen
Not applicable
666
Heidelberg, Mannheim, Singen, Ulm, Augsburg, Dachau, Erding, Ingolstadt
2024-07-01
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Bad Berka, Berlin, Bielefeld, Bremen, Cologne, Dachau, Dortmund, Dresden
2024-06-25
Active, closed
Pfizer
Observational
360
Freiburg im Breisgau, Kassel, Aachen, Andernach, Berlin, Cologne, Dachau, Frankfurt am Main
2024-05-08
Active, closed
Janssen-Cilag Ltd.
Phase 3
120
Augsburg, Berlin, Dachau, Frankfurt, Göttingen, Halle, Hanover, Kiel
2024-04-17
Recruiting
AstraZeneca
Phase 3
5,250
Ahrensburg, Augsburg, Bamberg, Berlin, Bonn, Bremen, Cottbus, Dachau
2024-02-21
Active, closed
AbbVie
Observational
1,200
Dachau, Lüneburg, Oldenburg, Minden, Buedelsdorf, Lübeck, Jena, Berlin
2024-02-19
Active, closed
AnaptysBio, Inc.
Phase 2
132
Berlin, Brandenburg, Dachau, Duisburg, Erlangen, Hamburg, Kiel, Ulm
2023-12-04
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Ulm, Dachau, Munich, Frankfurt am Main, Hanover, Lüneburg, Duisburg, Minden
2023-10-25
Recruiting
Population Health Research Institute
Not applicable
5,100
Cologne, Dachau, Frankfurt, Hamburg, Heide
2023-06-22
Active, closed
Alfasigma S.p.A.
Observational
509
Grünwald, Amberg, Dachau, Hamburg, Heidelberg, Kiel, Leipzig, Münster
2023-06-12
Active, closed
AbbVie
Observational
1,019
Heidelberg, Dachau, Erlangen, Kassel, Hanover, Minden, Remscheid, Worms
2023-06-09
Active, closed
AbbVie
Observational
400
Heidelberg, Winnenden, Augsburg, Dachau, Munich, Brandenburg an der Havel, Potsdam, Tostedt
2022-10-20
Active, closed
Janssen Research & Development, LLC
Phase 3
418
Dachau, Duisburg, Hanover, Jerichow, Lüneburg
2022-09-13
Active, closed
AbbVie
Observational
785
Dachau, Darmstadt, Frankfurt am Main, Kassel, Remscheid, Ludwigshafen am Rhein, Saarbrücken, Leipzig
2022-08-15
Active, closed
Janssen Research & Development, LLC
Phase 2
703
Berlin, Cologne, Dachau, Dresden, Duisburg, Erlangen, Essen, Frankfurt
2022-07-22
Active, closed
Janssen Research & Development, LLC
Phase 3
350
Berlin, Braunschweig, Cologne, Dachau, Duisburg, Halle, Hanover, Jerichow
2022-01-19
Recruiting
Technische Universität Dresden
Not applicable
240
Mannheim, Dresden, Ansbach, Augsburg, Berlin, Bonn, Braunschweig, Dachau
2021-01-01
Active, closed
Medstar Health Research Institute
Not applicable
3,100
Bad Oeynhausen, Cologne, Bad Segeberg, Dachau, Hamburg, Neuss, Rostock
2020-10-14
Active, closed
AbbVie
Phase 3
1,336
Freiburg im Breisgau, Heidelberg, Mannheim, Ulm, Dachau, Erlangen, Regensburg, Frankfurt am Main
2018-04-09
Recruiting
The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)
NCT03949972Glomerulosclerosis, Focal Segmental, Minimal Change Disease, Idiopathic Nephrotic Syndrome
Prof. Dr. Paul Brinkkoetter
Observational
500
Cologne, Aachen, Berlin, Bonn, Dachau, Erlangen, Essen, Heidelberg
2018-04-01
Rows per page Showing 1–35 of 35
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 October 2026. https://priyalifescience.com/clinical-trials-germany/city/dachau

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,062 studies in total at the last sync on 20 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 35 of those studies with a site in Dachau.

How many clinical trials are recruiting in Dachau?

17 of the 35 studies on this page are recruiting new participants as of the 20 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 18 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Dachau), 35 studies
PhaseStudiesRecruitingShare
Phase 313437.1%
Observational8222.9%
Phase 28622.9%
Not applicable4311.4%
Phase 2/3225.7%

Most active sponsors

Lead sponsors with the most studies (Dachau)
Lead sponsorStudiesRecruiting
Janssen Research & Development, LLC74
AbbVie60
Eli Lilly and Company44
Alfasigma S.p.A.10
AnaptysBio, Inc.10
AstraZeneca11
Cinclus Pharma Holding AB10
Deutsches Herzzentrum Muenchen11
GlaxoSmithKline10
Janssen-Cilag Ltd.10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.